Catherine E. Charron

544 citations

16 papers · 410 indexed · h-index 10

Impact in

Physiology
- Asthma and respiratory diseases
- Erythrocyte Function and Pathophysiology
Pulmonary and Respiratory Medicine
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Neonatal Respiratory Health Research
- Respiratory and Cough-Related Research

Papers in ⓘ

Molecular Biology 7
- Histone Deacetylase Inhibitors Research 3
Physiology 5
- Asthma and respiratory diseases 4

Co-authors: Kazuhiro Ito (13 shared papers)Ian M. Adcock (2 shared papers)Peter J. Barnes (3 shared papers)Masako To (3 shared papers)Christos Rossios (1 shared paper)Hidenori Wada (1 shared paper)Kenichi Akashi (2 shared papers)Yoshiki Kobayashi (1 shared paper)
Journals: European Respiratory Journal (3 papers)Transfusion (1 paper)Journal of Biological Chemistry (1 paper)Brain Research (1 paper)Journal of Medicinal Chemistry (1 paper)
Partner nations: United Kingdom Japan United States

In The Last Decade

Catherine E. Charron

16 papers receiving 396 citations

Peers

Countries citing papers authored by Catherine E. Charron

Since Specialization

Citations

This map shows the geographic impact of Catherine E. Charron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine E. Charron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine E. Charron more than expected).

Fields of papers citing papers by Catherine E. Charron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine E. Charron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine E. Charron. The network helps show where Catherine E. Charron may publish in the future.

Co-authors

The 25 scholars most cited alongside Catherine E. Charron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Catherine E. Charron Line = papers co-authored together Catherine E. Charron links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	A novel macrolide/fluoroketolide, solithromycin (CEM‐101), reverses corticosteroid insensitivity via phosphoinositide 3‐kinase pathway inhibition British Journal of Pharmacology ·Yoshiki Kobayashi, Hidenori Wada, Christos Rossios, Dai Takagi, Catherine E. Charron, Peter J. Barnes, Kazuhiro Ito	2013	65
2	Impact of protein acetylation in inflammatory lung diseases Pharmacology & Therapeutics ·Kazuhiro Ito, Catherine E. Charron, Ian M. Adcock	2007	64
3	Hypoxia-inducible Factor 1α Induces Corticosteroid-insensitive Inflammation via Reduction of Histone Deacetylase-2 Transcription Journal of Biological Chemistry ·Catherine E. Charron, Pai-Chien Chou, David J.C. Coutts, Vaibhav Kumar, Masako To, Kenichi Akashi, Liao Pinhu, Mark Griffiths, Ian M. Adcock, Peter J. Barnes, Kazuhiro Ito	2009	44
4	Mode of Glucocorticoid Actions in Airway Disease The Scientific World JOURNAL ·Kazuhiro Ito, Steve Getting, Catherine E. Charron	2006	41
5	RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-α and -γ selectivity, suppresses COPD inflammation European Respiratory Journal ·Catherine E. Charron, Paul Russell, Kazuhiro Ito, Simon Lea, Yasuo Kizawa, Charlie Brindley, Dave Singh	2017	39
6	Defect of Adaptation to Hypoxia in Patients With COPD Due to Reduction of Histone Deacetylase 7 CHEST Journal ·Masako To, Satoshi Yamamura, Kenichi Akashi, Catherine E. Charron, Kosuke Haruki, Peter J. Barnes, Kazuhiro Ito	2011	36
7	Quantitation of immunoglobulin classes and subclasses of autoantibodies bound to red cells in patients with and without hemolysis Transfusion ·M. Dubarry, Catherine E. Charron, B. Habibi, Y Bretagne, P. Lambin	1993	35
8	Atorvastatin in combination with inhaled beclometasone modulates inflammatory sputum mediators in smokers with asthma Pulmonary Pharmacology & Therapeutics ·Neil C. Thomson, Catherine E. Charron, Rekha Chaudhuri, Mark Spears, Kazuhiro Ito, Charles McSharry	2015	30
9	PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pahenu2 mice Brain Research ·Jennifer E. Embury, Catherine E. Charron, Anatoly E. Martynyuk, Andreas G. Zori, Bin Liu, Syed F. Ali, Neil E. Rowland, Philip J. Laipis	2006	24
10	Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant Asthma Journal of Medicinal Chemistry ·Stuart Onions, Kazuhiro Ito, Catherine E. Charron, Richard J. Brown, Marie A. Colucci, Fritz Frickel, George W. Hardy, Kevin Joly, John King-Underwood, Yasuo Kizawa, Ian Knowles, P. John Murray, Andrew Novak, Anjna Rani, Garth Rapeport, Alun Smith, Peter Strong, David M. Taddei, Jonathan G. Williams	2016	17
11	Safety, pharmacokinetic and pharmacodynamic profile of RV568, a narrow spectrum kinase inhibitor, following repeat inhaled dosing in COPD patients European Respiratory Journal ·Paul Russell, Lindsey Cass, Kazuhiro Ito, Catherine E. Charron, Pete Strong, Garth Rapeport, Dave Singh	2013	4
12	RV568, a narrow spectrum kinase inhibitor (NSKI), inhibits virus induced nasal interleukin-8 (IL8) in the human viral challenge model where healthy adult male volunteers were experimentally inoculated with live respiratory syncytial virus European Respiratory Journal ·Lindsey Cass, Kazuhiro Ito, Catherine E. Charron, Pete Strong, Chantelle Norton, Anthony Gilbert, Rob Lambkin‐Williams, Alex Mann, Garth Rapeport	2013	3
13	Superior Effects Of RV568, A Novel Narrow Spectrum Kinase Inhibitor, To BIRB796, A P38MAPK Inhibitor, On Pro-Inflammatory Cytokine Roduction In Macrophages Catherine E. Charron, Matthew Coates, Kazuhiro Ito, Chaitanya Vuppusetty, Masako To, J. Clifford Murray, Peter Strong, Garth Rapeport	2011	3
14	Effects Of RV568, A Novel Narrow Spectrum Kinase Inhibitor, On Pro-Inflammatory Cytokine Production In Epithelial Cells Isolated From Asthma And COPD Catherine E. Charron, Matthew Coates, Kazuhiro Ito	2011	2
15	Effects Of RV1088, A Novel Narrow Spectrum Kinase Inhibitor, On Pro-Inflammatory Cytokine Production In Epithelial Cells Isolated From Asthma And COPD Catherine E. Charron, Matthew Coates, Kazuhiro Ito	2011	2
16	PUR1800 (RV1162), A novel narrow spectrum kinase inhibitor, but not Fluticasone, reduces TNFa-induced cytokine release by primary bronchial epithelial cells from healthy volunteers and COPD patients Aidan K. Curran, Catherine E. Charron, Paul Russell, David L. Hava	2018	1

About Catherine E. Charron

Catherine E. Charron is a scholar working on Molecular Biology, Physiology, Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 16 papers that have together received 410 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (4 papers), Cytokine Signaling Pathways and Interactions (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Estrogen and related hormone effects (2 papers), Metabolism and Genetic Disorders (1 paper) and Analytical Methods in Pharmaceuticals (1 paper). The work is most often cited by research in Physiology (157 citations), Pulmonary and Respiratory Medicine (124 citations), Cancer Research (53 citations), Immunology (71 citations) and Emergency Medical Services (22 citations). Catherine E. Charron has collaborated with scholars based in United Kingdom, Japan and United States. Frequent co-authors include Kazuhiro Ito, Ian M. Adcock, Peter J. Barnes, Masako To, Christos Rossios, Hidenori Wada, Kenichi Akashi, Yoshiki Kobayashi, Dai Takagi and P. Lambin. Their work appears in journals such as European Respiratory Journal, Transfusion, Journal of Biological Chemistry, Brain Research and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact